Trial Profile
Tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa infections
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2011
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Cystic fibrosis; Pseudomonal infections
- Focus Therapeutic Use
- Acronyms EVOLVE
- 06 Apr 2011 New trial record
- 01 Mar 2011 Primary endpoint 'Forced-expiratory-volume-in-1-second' has been met.